There are still some pharmaceutical manufacturers who believe maintaining internal teams for manual chargeback processing saves money.  Advances in technology and market competition have dramatically reduced the cost of more efficient solutions. Embracing a new strategy for processing chargebacks is necessary because wholesalers have increasingly sophisticated systems that can overwhelm manual processing, resulting in reduced cost control and increased financial risk.  A new suite of automated...